ABOUT PANCREATIC CANCER
In 2018, an estimated 55,440 Americans will be diagnosed with pancreatic cancer and 44,330 will die from the disease
The disease is the 3rd leading cause of cancer-related deaths in the United States
Only 10% of individuals with pancreatic cancer are diagnosed at the local stage
Pancreatic cancer is one of the deadliest cancers with the lowest survival rate at just 9 percent
Around 2020, estimates show that pancreatic cancer will rise to the 2nd leading cause of cancer-related deaths
Known Risk Factors
The cause of most pancreatic cancer is unknown
Risk factors for developing pancreatic cancer include: family history, age, chronic or hereditary pancreatitis, smoking, obesity, long-standing diabetes
There is no early detection test for pancreatic cancer and few effective treatments are available
Patients with pancreatic cancer typically experience vague symptoms, which could also be confused with many other abdominal or gastrointestinal issues. These symptoms include:
- Abdominal and/or mid-to-upper back pain
- Weight loss
- Nausea/loss of appetite
- Change in stool
- New onset diabetes
SURGERY is only possible in less than 20 percent of patients with adenocarcinoma (which accounts for more than 90 percent of all pancreatic cancers).
CHEMOTHERAPY is usually offered when tumors cannot be removed surgically and can be used before and/or after surgery.
RADIATION is sometimes offered before or after surgery and can be combined with chemotherapy.
CLINICAL TRIALS are an option for eligible pancreatic cancer patients and may offer a patient the best opportunity for a positive outcome.